NARIN TIPTON: Open Payments
NPI 1477720654 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,469 in 98 payments from 16 companies in 2025. Trend: 2023 $4,665 · 2024 $5,131 · 2025 $2,469
Food & beverage: $2,469
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $641 |
| Janssen Biotech, Inc. | 12 | $304 |
| Regeneron Healthcare Solutions, Inc. | 5 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $201 |
| Lilly USA, LLC | 6 | $190 |
| Madrigal Pharmaceuticals | 4 | $164 |
| QOL Medical, LLC | 5 | $146 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $129 |
| Celltrion USA Inc. | 6 | $109 |
| PFIZER INC. | 5 | $77 |
Products named: TREMFYA, RINVOQ, OMVOH, REZDIFFRA, ENTYVIO, Sucraid, MAVYRET, DUPIXENT.
Industry payments across MO — which companies pay providers there.
